{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:09:02Z","timestamp":1790712542644,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C0992"],"award-info":[{"award-number":["HI16C0992"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1I1A1A01069145"],"award-info":[{"award-number":["NRF-2022R1I1A1A01069145"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis is a chronic inflammatory disorder characterized by pathogenic hyperproliferation of keratinocytes and immune dysregulation. Currently, objective evaluation tools reflecting the severity of psoriasis are insufficient. MicroRNAs in extracellular vesicles (EV miRNAs) have been shown to be potential biomarkers for various inflammatory diseases. Our objective was to investigate the possibility of plasma-derived EV miRNAs as a marker for the psoriasis disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>EVs were extracted from the plasma of 63 patients with psoriasis and 12 with Beh\u00e7et\u2019s disease. We performed next-generation sequencing of the plasma-derived EV miRNAs from the psoriasis patients. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to validate the level of EV miRNA expression. In situ hybridization was used to discern the anatomical location of miRNAs. qRT-PCR, western blotting, and cell counting kits (CCKs) were used to investigate IGF-1 signaling in cells transfected with miRNA mimics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 19 differentially expressed EV miRNAs and validated the top three up-and down-regulated EV miRNAs. Among these, miR-625-3p was significantly increased in patients with severe psoriasis in both plasma and skin and most accurately distinguished moderate-to-severe psoriasis from mild-to-moderate psoriasis. It was produced and secreted by keratinocytes upon stimulation. We also observed a significant intensification of IGF-1 signalling and increased cell numbers in the miR-625-3p mimic transfected cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We propose keratinocyte-derived EV miR-625-3p as a novel and reliable biomarker for estimating the severity of psoriasis. This biomarker could objectively evaluate the severity of psoriasis in the clinical setting and might serve as a potential therapeutic target.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> None.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-024-05030-z","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T02:01:23Z","timestamp":1709517683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Keratinocyte-derived circulating microRNAs in extracellular vesicles: a novel biomarker of psoriasis severity and potential therapeutic target"],"prefix":"10.1186","volume":"22","author":[{"given":"Young Joon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Seul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Youn","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0232-7704","authenticated-orcid":false,"given":"Eun-So","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"5030_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397:1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"key":"5030_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.17219\/acem\/69804","volume":"26","author":"A Bo\u017cek","year":"2017","unstructured":"Bo\u017cek A, Reich A. The reliability of three psoriasis assessment tools: psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26:851\u20136. https:\/\/doi.org\/10.17219\/acem\/69804.","journal-title":"Adv Clin Exp Med"},{"issue":"Suppl 2","key":"5030_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1468-3083.2009.03562.x","volume":"24","author":"E Puzenat","year":"2010","unstructured":"Puzenat E, Bronsard V, Prey S, Gourraud PA, Aractingi S, Bagot M, et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010;24(Suppl 2):10\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03562.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5030_CR4","doi-asserted-by":"publisher","first-page":"e15000","DOI":"10.1111\/ijcp.15000","volume":"75","author":"AE Ibrahim","year":"2021","unstructured":"Ibrahim AE, Magdy M, Khalaf EM, Mostafa A, Arafa A. Teledermatology in the time of COVID-19. Int J Clin Pract. 2021;75:e15000. https:\/\/doi.org\/10.1111\/ijcp.15000.","journal-title":"Int J Clin Pract"},{"key":"5030_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjd.21627","volume":"187","author":"R Ramessur","year":"2022","unstructured":"Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N, et al. Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol. 2022;187:481\u201393. https:\/\/doi.org\/10.1111\/bjd.21627.","journal-title":"Br J Dermatol"},{"key":"5030_CR6","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.7150\/thno.45488","volume":"10","author":"S Shao","year":"2020","unstructured":"Shao S, Fang H, Li Q, Wang G. Extracellular vesicles in inflammatory skin disorders: from pathophysiology to treatment. Theranostics. 2020;10:9937\u201355. https:\/\/doi.org\/10.7150\/thno.45488.","journal-title":"Theranostics"},{"key":"5030_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2018.02.002","volume":"60","author":"C L\u00e4sser","year":"2018","unstructured":"L\u00e4sser C, Jang SC, L\u00f6tvall J. Subpopulations of extracellular vesicles and their therapeutic potential. Mol Aspects Med. 2018;60:1\u201314. https:\/\/doi.org\/10.1016\/j.mam.2018.02.002.","journal-title":"Mol Aspects Med"},{"key":"5030_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/exd.13857","volume":"28","author":"WM Wang","year":"2019","unstructured":"Wang WM, Wu C, Jin HZ. Exosomes in chronic inflammatory skin diseases and skin tumors. Exp Dermatol. 2019;28:213\u20138. https:\/\/doi.org\/10.1111\/exd.13857.","journal-title":"Exp Dermatol"},{"key":"5030_CR9","doi-asserted-by":"publisher","first-page":"153303382110412","DOI":"10.1177\/15330338211041203","volume":"20","author":"SP Kodam","year":"2021","unstructured":"Kodam SP, Ullah M. Diagnostic and therapeutic potential of extracellular vesicles. Technol Cancer Res Treat. 2021;20:15330338211041204. https:\/\/doi.org\/10.1177\/15330338211041203.","journal-title":"Technol Cancer Res Treat"},{"key":"5030_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jdv.16203","volume":"34","author":"L Pasquali","year":"2020","unstructured":"Pasquali L, Svedbom A, Srivastava A, Ros\u00e9n E, Lindqvist U, St\u00e5hle M, et al. Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis. J Eur Acad Dermatol Venereol. 2020;34:1248\u201356. https:\/\/doi.org\/10.1111\/jdv.16203.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5030_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jid.2020.04.021","volume":"141","author":"ZY Wang","year":"2021","unstructured":"Wang ZY, Yan BX, Zhou Y, Chen XY, Zhang J, Cai SQ, et al. miRNA profiling of extracellular vesicles reveals biomarkers for psoriasis. J Invest Dermatol. 2021;141:185-9.e4. https:\/\/doi.org\/10.1016\/j.jid.2020.04.021.","journal-title":"J Invest Dermatol"},{"key":"5030_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR-ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD). The international criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338\u201347. https:\/\/doi.org\/10.1111\/jdv.12107.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5030_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","volume":"4","author":"M Suzuki Kurokawa","year":"2004","unstructured":"Suzuki Kurokawa M, Suzuki N. Behcet\u2019s disease. Clin Exp Med. 2004;4:10\u201320. https:\/\/doi.org\/10.1007\/s10238-004-0033-4.","journal-title":"Clin Exp Med"},{"key":"5030_CR14","doi-asserted-by":"publisher","first-page":"29289","DOI":"10.3402\/jev.v5.29289","volume":"5","author":"CS Hong","year":"2016","unstructured":"Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 2016;5:29289. https:\/\/doi.org\/10.3402\/jev.v5.29289.","journal-title":"J Extracell Vesicles"},{"key":"5030_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedl\u00e4nder","year":"2012","unstructured":"Friedl\u00e4nder MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40:37\u201352. https:\/\/doi.org\/10.1093\/nar\/gkr688.","journal-title":"Nucleic Acids Res"},{"key":"5030_CR16","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68-73. https:\/\/doi.org\/10.1093\/nar\/gkt1181.","journal-title":"Nucleic Acids Res"},{"key":"5030_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2105-14-219","volume":"14","author":"J Sun","year":"2013","unstructured":"Sun J, Nishiyama T, Shimizu K, Kadota K. TCC: an R package for comparing tag count data with robust normalization strategies. BMC Bioinformatics. 2013;14:219. https:\/\/doi.org\/10.1186\/1471-2105-14-219.","journal-title":"BMC Bioinformatics"},{"key":"5030_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Stat Soc B"},{"key":"5030_CR19","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.3390\/ijms20184353","volume":"20","author":"S Donati","year":"2019","unstructured":"Donati S, Ciuffi S, Brandi ML. Human circulating miRNAs real-time qRT-PCR-based analysis: an overview of endogenous reference genes used for data normalization. Int J Mol Sci. 2019;20:4353. https:\/\/doi.org\/10.3390\/ijms20184353.","journal-title":"Int J Mol Sci"},{"key":"5030_CR20","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331. https:\/\/doi.org\/10.1093\/nar\/gkz757.","journal-title":"Nucleic Acids Res"},{"key":"5030_CR21","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/gb-2010-11-8-r90","volume":"11","author":"D Betel","year":"2010","unstructured":"Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010;11:R90. https:\/\/doi.org\/10.1186\/gb-2010-11-8-r90.","journal-title":"Genome Biol"},{"key":"5030_CR22","doi-asserted-by":"publisher","first-page":"D148","DOI":"10.1093\/nar\/gkz896","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YCD, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA\u2013target interaction database. Nucleic Acids Res. 2020;48:D148\u201354. https:\/\/doi.org\/10.1093\/nar\/gkz896.","journal-title":"Nucleic Acids Res"},{"key":"5030_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinformatics"},{"key":"5030_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ecns.2014.07.005","volume":"10","author":"S Prion","year":"2014","unstructured":"Prion S, Haerling KA. Making sense of methods and measurement: spearman-rho ranked-order correlation coefficient. Clin Simul Nurs. 2014;10:535\u20136. https:\/\/doi.org\/10.1016\/j.ecns.2014.07.005.","journal-title":"Clin Simul Nurs"},{"key":"5030_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-021-02775-9","volume":"19","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wang Y, Wei S, Zhou C, Yu J, Wang G, et al. Extracellular vesicles isolated by size-exclusion chromatography present suitability for RNomics analysis in plasma. J Transl Med. 2021;19:104. https:\/\/doi.org\/10.1186\/s12967-021-02775-9.","journal-title":"J Transl Med"},{"key":"5030_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ijc.11487","volume":"107","author":"R Baserga","year":"2003","unstructured":"Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer. 2003;107:873\u20137. https:\/\/doi.org\/10.1002\/ijc.11487.","journal-title":"Int J Cancer"},{"key":"5030_CR27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1039\/c6sc01829g","volume":"8","author":"H Qian","year":"2017","unstructured":"Qian H, Tay CY, Setyawati MI, Chia SL, Lee DS, Leong DT. Protecting microRNAs from RNase degradation with steric DNA nanostructures. Chem Sci. 2017;8:1062\u20137. https:\/\/doi.org\/10.1039\/c6sc01829g.","journal-title":"Chem Sci"},{"key":"5030_CR28","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.3390\/ijms23074005","volume":"23","author":"F L\u00e4ttekivi","year":"2022","unstructured":"L\u00e4ttekivi F, Guljavina I, Midekessa G, Viil J, Heath PR, B\u00e6k R, et al. Profiling blood serum extracellular vesicles in plaque psoriasis and psoriatic arthritis patients reveals potential disease biomarkers. Int J Mol Sci. 2022;23:4005. https:\/\/doi.org\/10.3390\/ijms23074005.","journal-title":"Int J Mol Sci"},{"key":"5030_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cca.2019.09.005","volume":"499","author":"R Szelenberger","year":"2019","unstructured":"Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M. Plasma microRNA as a novel diagnostic. Clin Chim Acta. 2019;499:98\u2013107. https:\/\/doi.org\/10.1016\/j.cca.2019.09.005.","journal-title":"Clin Chim Acta"},{"key":"5030_CR30","doi-asserted-by":"publisher","first-page":"575712","DOI":"10.3389\/fimmu.2020.575712","volume":"11","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zhao M, Qianjin Lu. Extracellular vesicles in rheumatoid arthritis and systemic lupus erythematosus: functions and applications. Front Immunol. 2021;11:575712. https:\/\/doi.org\/10.3389\/fimmu.2020.575712.","journal-title":"Front Immunol"},{"key":"5030_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-018-0192-7","volume":"7","author":"RE Lane","year":"2018","unstructured":"Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med. 2018;7:1\u201311. https:\/\/doi.org\/10.1186\/s40169-018-0192-7.","journal-title":"Clin Transl Med"},{"key":"5030_CR32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/pharmaceutics15041216","volume":"15","author":"WQ Lim","year":"2023","unstructured":"Lim WQ, Michelle Luk KH, Lee KY, Nurul N, Loh SJ, et al. Small extracellular vesicles\u2019 miRNAs: Biomarkers and therapeutics for neurodegenerative diseases. Pharmaceutics. 2023;15:1216. https:\/\/doi.org\/10.3390\/pharmaceutics15041216.","journal-title":"Pharmaceutics"},{"key":"5030_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.molonc.2013.02.016","volume":"7","author":"MH Rasmussen","year":"2013","unstructured":"Rasmussen MH, Jensen NF, Tarpgaard LS, Qvortrup C, R\u00f8mer MU, Stenvang J, et al. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. Mol Oncol. 2013;7:637\u201346. https:\/\/doi.org\/10.1016\/j.molonc.2013.02.016.","journal-title":"Mol Oncol"},{"key":"5030_CR34","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.18632\/oncotarget.14710","volume":"8","author":"W Fang","year":"2017","unstructured":"Fang W, Fan Y, Fa Z, Xu J, Yu H, Li P, et al. microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget. 2017;8:13253\u201363. https:\/\/doi.org\/10.18632\/oncotarget.14710.","journal-title":"Oncotarget"},{"key":"5030_CR35","doi-asserted-by":"publisher","first-page":"845094","DOI":"10.3389\/fmed.2022.845094","volume":"9","author":"M Zhang","year":"2022","unstructured":"Zhang M, Xiong F, Zhang S, Guo W, He Y. Crucial roles of miR-625 in human cancer. Front Med. 2022;9:845094. https:\/\/doi.org\/10.3389\/fmed.2022.845094.","journal-title":"Front Med"},{"key":"5030_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/exd.14497","volume":"31","author":"\u00c5\u00d8 Solvin","year":"2022","unstructured":"Solvin \u00c5\u00d8, Chawla K, Olsen LC, Hegre SA, Danielsen K, Jenssen M, et al. MicroRNA profiling of psoriatic skin identifies 11 miRNAs associated with disease severity. Exp Dermatol. 2022;31:535\u201347. https:\/\/doi.org\/10.1111\/exd.14497.","journal-title":"Exp Dermatol"},{"key":"5030_CR37","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.jid.2019.05.019","volume":"139","author":"A Srivastava","year":"2019","unstructured":"Srivastava A, Meisgen F, Pasquali L, Munkhammar S, Xia P, St\u00e5hle M, et al. Next-generation sequencing identifies the keratinocyte-specific miRNA signature of psoriasis. J Invest Dermatol. 2019;139:2547-50.e12. https:\/\/doi.org\/10.1016\/j.jid.2019.05.019.","journal-title":"J Invest Dermatol"},{"key":"5030_CR38","doi-asserted-by":"publisher","first-page":"13241","DOI":"10.1096\/fj.201900642R","volume":"33","author":"M Jiang","year":"2019","unstructured":"Jiang M, Fang H, Shao S, Dang E, Zhang J, Qiao P, et al. Keratinocyte exosomes activate neutrophils and enhance skin inflammation in psoriasis. FASEB J. 2019;33:13241\u201353. https:\/\/doi.org\/10.1096\/fj.201900642R.","journal-title":"FASEB J"},{"key":"5030_CR39","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.3892\/mmr.2017.7492","volume":"16","author":"XW Cai","year":"2017","unstructured":"Cai XW, Zhu R, Ran L, Li YQ, Huang K, Peng J, et al. A novel non-contact communication between human keratinocytes and T cells: exosomes derived from keratinocytes support superantigen-induced proliferation of resting T cells. Mol Med Rep. 2017;16:7032\u20138. https:\/\/doi.org\/10.3892\/mmr.2017.7492.","journal-title":"Mol Med Rep"},{"key":"5030_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/exd.12230","volume":"22","author":"K Kotzerke","year":"2013","unstructured":"Kotzerke K, Mempel M, Aung T, Wulf GG, Urlaub H, Wenzel D, et al. Immunostimulatory activity of murine keratinocyte-derived exosomes. Exp Dermatol. 2013;22:650\u20135. https:\/\/doi.org\/10.1111\/exd.12230.","journal-title":"Exp Dermatol"},{"key":"5030_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.immuni.2020.03.013","volume":"52","author":"D Ditoro","year":"2020","unstructured":"Ditoro D, Harbour SN, Bando JK, Benavides G, Witte S, Laufer VA, et al. Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity. Immunity. 2020;52:650-67.e10. https:\/\/doi.org\/10.1016\/j.immuni.2020.03.013.","journal-title":"Immunity"},{"key":"5030_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1365-4632.2008.03810.x","volume":"47","author":"MG Ozden","year":"2008","unstructured":"Ozden MG, Ilter N, Suer OE, Solaktekin N, G\u00fcrer MA. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate. Int J Dermatol. 2008;47:1177\u201383. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03810.x.","journal-title":"Int J Dermatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05030-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T14:03:35Z","timestamp":1709820215000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5030"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05030-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Ajou University Hospital (approval number: AJIRB-BMR-OBS-15-398) and conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all participants prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript and agree with submission to Biomarker Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}